
Court Cancels ‘Click-to-Cancel’ Rule
It won’t get any easier to cancel those annoying subscriptions.
Fust et al. v. Gilead Sciences, Inc.
23-at-1244, E.D. Cal.
(Sept. 2023)
Remdesivir
Falsely marketing Remdesivir as safe and effective against COVID-19 without disclosing its limitations and adverse events, including fatalities
Pending
It won’t get any easier to cancel those annoying subscriptions.
This soft drink reminds consumers of the good old days.
What you need to know about this offer.
What’s this kidfluencer doing promoting a “youth cream”?
Emily Baker-White, Forbes